These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 2901667

  • 21. Attenuation of thyroid hormone action by 1,25-dihydroxyvitamin D3 in pituitary cells.
    Kaji H, Hinkle PM.
    Endocrinology; 1989 Feb; 124(2):930-6. PubMed ID: 2463908
    [Abstract] [Full Text] [Related]

  • 22. Constitutive transactivation by the thyroid hormone receptor and a novel pattern of activity of its oncogenic homolog v-ErbA in Xenopus oocytes.
    Nagl SB, Nelson CC, Romaniuk PJ, Allison LA.
    Mol Endocrinol; 1995 Nov; 9(11):1522-32. PubMed ID: 8584030
    [Abstract] [Full Text] [Related]

  • 23. Sodium butyrate selectively alters thyroid hormone receptor gene expression in GH3 cells.
    Lazar MA.
    J Biol Chem; 1990 Oct 15; 265(29):17474-7. PubMed ID: 2211641
    [Abstract] [Full Text] [Related]

  • 24. Thyroid hormone responsiveness is developmentally regulated in the rat small intestine: a possible role for the alpha-2 receptor variant.
    Hodin RA, Meng S, Chamberlain SM.
    Endocrinology; 1994 Aug 15; 135(2):564-8. PubMed ID: 8033803
    [Abstract] [Full Text] [Related]

  • 25. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).
    Saatcioglu F, Bartunek P, Deng T, Zenke M, Karin M.
    Mol Cell Biol; 1993 Jun 15; 13(6):3675-85. PubMed ID: 8098843
    [Abstract] [Full Text] [Related]

  • 26. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.
    Schroeder C, Gibson L, Zenke M, Beug H.
    Oncogene; 1992 Feb 15; 7(2):217-27. PubMed ID: 1347914
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds.
    Usala SJ, Tennyson GE, Bale AE, Lash RW, Gesundheit N, Wondisford FE, Accili D, Hauser P, Weintraub BD.
    J Clin Invest; 1990 Jan 15; 85(1):93-100. PubMed ID: 2153155
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Isolation and characterization of rat cDNA clones for two distinct thyroid hormone receptors.
    Murray MB, Zilz ND, McCreary NL, MacDonald MJ, Towle HC.
    J Biol Chem; 1988 Sep 05; 263(25):12770-7. PubMed ID: 2457590
    [Abstract] [Full Text] [Related]

  • 31. Identification of a thyroid hormone receptor that is pituitary-specific.
    Hodin RA, Lazar MA, Wintman BI, Darling DS, Koenig RJ, Larsen PR, Moore DD, Chin WW.
    Science; 1989 Apr 07; 244(4900):76-9. PubMed ID: 2539642
    [Abstract] [Full Text] [Related]

  • 32. Antibodies against restricted sequences in human c-ErbA hinge domain recognize differentially natural mammalian alpha- or beta-type triiodothyronine receptors and interfere differently with hormone binding.
    Bismuth J, Lenoir C, Teboul M, Daadi M, Giorgilli G, Bonne J, Macchia E, Planells R, Torresani J.
    Eur J Endocrinol; 1995 Mar 07; 132(3):347-56. PubMed ID: 7889185
    [Abstract] [Full Text] [Related]

  • 33. Constitutive expression of the orphan receptor, Rev-erbA alpha, inhibits muscle differentiation and abrogates the expression of the myoD gene family.
    Downes M, Carozzi AJ, Muscat GE.
    Mol Endocrinol; 1995 Dec 07; 9(12):1666-78. PubMed ID: 8614403
    [Abstract] [Full Text] [Related]

  • 34. Characterization of the domain structure of chick c-erbA by deletion mutation: in vitro translation and cell transfection studies.
    Horowitz ZD, Yang CR, Forman BM, Casanova J, Samuels HH.
    Mol Endocrinol; 1989 Jan 07; 3(1):148-56. PubMed ID: 2464752
    [Abstract] [Full Text] [Related]

  • 35. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.
    Rascle A, Ghysdael J, Samarut J.
    Oncogene; 1994 Oct 07; 9(10):2853-67. PubMed ID: 7916146
    [Abstract] [Full Text] [Related]

  • 36. Deletion of the thyroid hormone beta1 receptor increases basal and triiodothyronine-induced growth hormone messenger ribonucleic acid in GH3 cells.
    Ball SG, Ikeda M, Chin WW.
    Endocrinology; 1997 Aug 07; 138(8):3125-32. PubMed ID: 9231759
    [Abstract] [Full Text] [Related]

  • 37. c-erbA alpha/T3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis or differentiation and are antagonized by the v-erbA oncogene.
    Gandrillon O, Ferrand N, Michaille JJ, Roze L, Zile MH, Samarut J.
    Oncogene; 1994 Mar 07; 9(3):749-58. PubMed ID: 7906409
    [Abstract] [Full Text] [Related]

  • 38. Relationship of c-erbA mRNA content to tissue triiodothyronine nuclear binding capacity and function in developing and adult rats.
    Strait KA, Schwartz HL, Perez-Castillo A, Oppenheimer JH.
    J Biol Chem; 1990 Jun 25; 265(18):10514-21. PubMed ID: 2162351
    [Abstract] [Full Text] [Related]

  • 39. Epidermal growth factor decreases thyroid hormone receptors and attenuates thyroid hormone responses in GH4C1 cells.
    Kaji H, Hinkle PM.
    Endocrinology; 1987 Feb 25; 120(2):537-43. PubMed ID: 3492366
    [Abstract] [Full Text] [Related]

  • 40. Retinoic acid decreases nuclear triiodothyronine receptor expression and impairs an early step of adipose differentiation in the thyroid hormone-sensitive mouse Ob 17 preadipocyte cell line.
    Teboul M, Bismuth J, Gharbi-Chihi J, Vallette A, Bonne J, Ghiringhelli O, Torresani J.
    Endocrinology; 1992 Mar 25; 130(3):1475-82. PubMed ID: 1311241
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.